Search Orphan Drug Designations and Approvals
-
Generic Name: | N-163 beta-glucan |
---|---|
Date Designated: | 08/21/2024 |
Orphan Designation: | treatment of Duchenne muscular dystrophy |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
GN Corporation Co. Ltd. 3-8, Wakamatsu Kofu 400-0866 Japan The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-